Mohamed Kharfan-Dabaja, MD, MBA(@MKD_BMT) 's Twitter Profileg
Mohamed Kharfan-Dabaja, MD, MBA

@MKD_BMT

Vice Chair of Hematology. Director of Blood Marrow and Transplantation and Cellular Therapies.@MayoClinic @MayoCancerCare

ID:1393292267323076612

linkhttps://mayocl.in/3CrUJdl calendar_today14-05-2021 19:50:31

327 Tweets

1,6K Followers

693 Following

Mehdi Hamadani, MD(@MediHumdani) 's Twitter Profile Photo

CAR T-cell Therapy in Mantle cell with sCNS Involvement.
Active disease PFS only 25%, without active disease about 33%. Perhaps needs post CT maintenance?
Mazyar Shadman, MD MPH Gulrayz Ahmed Farrukh Awan Tim Fenske Madiha Iqbal MD Mohamed Kharfan-Dabaja, MD, MBA MCW Cancer Center
ashpublications.org/bloodadvances/…

account_circle
VJHemOnc(@VJHemOnc) 's Twitter Profile Photo

What are the outcomes and unmet needs of patients with transfusion-dependent thalassemia?

Ali Taher of American University of Beirut Medical Center shares a global perspective on this in an interview from . 🌎

Click here to watch:
👉 ow.ly/JyIU50RhYO2

The EBMT

account_circle
Aref Al-Kali(@AlkaliDr) 's Twitter Profile Photo

Today was part I of Dr memoire of his journey to medicine narrated by himself ♥️ under series. The spark to go into medicine was a book written by he read in high school 👏 1944.

Mayo Clinic
thedigitalpress.org/kyle_memoir/

account_circle
Razan Mohty(@Razan_Mohty) 's Twitter Profile Photo

Our review on 'Post-transplant cyclophosphamide or cell selection in haploidentical allogeneic hematopoietic cell transplantation?'
tandfonline.com/doi/full/10.10…

Thank you, Mohamed Kharfan-Dabaja, MD, MBA and Dr Al-kadhimi

See below some take-home messages:

🧵🧵

account_circle
Mohamad Mohty(@Mohty_EBMT) 's Twitter Profile Photo

Outpatient CAR T-Cell Therapy as Standard of Care: Current Perspectives and Considerations.
just Published in Clinical Hematology International the official journal of ⁦IACH⁩ ⁦Ola Oluwole⁩ ⁦Bipin Savani⁩ ⁦Uriel Suárez⁩ chi.scholasticahq.com/article/115793

account_circle
Talha Badar(@TalhaBadarMD) 's Twitter Profile Photo

Efficacy of autologous and allogeneic hematopoietic cell transplantation in APL: systemic review and meta-analysis
sciencedirect.com/science/articl…
A big shout out to Razan Mohty for leading this effort! Congratulation to all co-authors at Mayo Clinic, Florida.

Highlights:
10% of pts

account_circle
Mohamad Mohty(@Mohty_EBMT) 's Twitter Profile Photo

“CAR-T Therapy for CLL: What is the supporting evidence so far?” A comprehensive review published in Clin Hematol Int. Official journal of ⁦IACH
CLL Advocates Network⁩ ⁦Razan Mohty⁩ ⁦Mohamed Kharfan-Dabaja, MD, MBA⁩ ⁦@HealthTreeCLL⁩ ⁦ELLyE l’Association #Lymphomes #LLC chi.scholasticahq.com/article/88382-…

account_circle
ASTCT(@ASTCT) 's Twitter Profile Photo

Congratulations to ASTCT Survivorship SIG Lifetime Achievement Award winner Bipin Savani of Vanderbilt University. 🎉 Thank you for your contributions to the transplantation and cellular therapy field.

account_circle
ASTCT(@ASTCT) 's Twitter Profile Photo

Congratulations to ASTCT Committee on Practice Guidelines Distinguished Service Award winner Ambuj Kumar of USF Health Medicine. 🎉 Thank you for your contributions to the transplantation and cellular therapy field.

account_circle
Mohamed Kharfan-Dabaja, MD, MBA(@MKD_BMT) 's Twitter Profile Photo

This procedure replaces damaged cells with healthy stem cells, collected either from the patient or a generous donor. It's a dynamic treatment that can also tackle an array of blood disorders, including anemias and immune deficiencies.

This procedure replaces damaged cells with healthy stem cells, collected either from the patient or a generous donor. It's a dynamic treatment that can also tackle an array of blood disorders, including anemias and immune deficiencies. #InnovationStartsAtMayo
account_circle
Mohamed Kharfan-Dabaja, MD, MBA(@MKD_BMT) 's Twitter Profile Photo

When he isn't at the forefront of blood and cellular therapies, Dr. Kharfan-Dabaja enjoys traveling and spending time with his family. Meet the man behind the medicine.

Learn more: mayocl.in/3CrUJdl

When he isn't at the forefront of blood and cellular therapies, Dr. Kharfan-Dabaja enjoys traveling and spending time with his family. Meet the man behind the medicine. #InnovationStartsAtMayo Learn more: mayocl.in/3CrUJdl
account_circle
Mohamed Kharfan-Dabaja, MD, MBA(@MKD_BMT) 's Twitter Profile Photo

In the world of medicine, information is power. At Mayo Clinic, we aim to empower patients with resources, guides, and the most up-to-date information about diseases, conditions, and treatments. Knowledge is the first step towards healing.

In the world of medicine, information is power. At @MayoClinic, we aim to empower patients with resources, guides, and the most up-to-date information about diseases, conditions, and treatments. Knowledge is the first step towards healing. #InnovationStartsAtMayo
account_circle